{
    "Trade/Device Name(s)": [
        "Xpert\u00ae C. difficile",
        "C. difficile Assay",
        "Clostridium difficile identification and differentiation system"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K091109",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081920"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LLH"
    ],
    "Summary Letter Date": "June 22, 2009",
    "Summary Letter Received Date": "June 23, 2009",
    "Submission Date": "June 21, 2009",
    "Regulation Number(s)": [
        "21 CFR 866.2660"
    ],
    "Regulation Name(s)": [
        "Microorganism differentiation and detection device"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Clostridium difficile toxin B gene (tcdB)"
    ],
    "Specimen Type(s)": [
        "Unformed (liquid or soft) stool"
    ],
    "Specimen Container(s)": [
        "Tube with elution reagent",
        "Disposable fluidic cartridge"
    ],
    "Instrument(s)/Platform(s)": [
        "Cepheid GeneXpert Dx System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Automated nucleic acid amplification"
    ],
    "Methodologies": [
        "Multiplex real-time PCR",
        "Qualitative nucleic acid amplification"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert C. difficile qualitative real-time PCR assay for detection of toxin B gene sequences from stool specimens",
    "Indications for Use Summary": "Aids in the rapid diagnosis of Clostridium difficile infection by detecting toxin B gene sequences from unformed stool specimens in patients suspected of CDI",
    "fda_folder": "Microbiology"
}